scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00296-019-04451-0 |
P698 | PubMed publication ID | 31606775 |
P50 | author | Virginia Pascual-Ramos | Q88332816 |
Irazú Contreras-Yáñez | Q89702127 | ||
Guillermo Guaracha-Basáñez | Q90673381 | ||
P2860 | cites work | The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review | Q26864018 |
Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients | Q30235042 | ||
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update | Q30244903 | ||
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
Clinical inertia | Q34428121 | ||
The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners | Q84207842 | ||
Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators | Q88041807 | ||
Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america | Q34495257 | ||
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment | Q34563216 | ||
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
Translating patient education theory into practice: developing material to address the cardiovascular education needs of people with rheumatoid arthritis. | Q35069789 | ||
Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and | Q35185494 | ||
Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study | Q35617716 | ||
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters | Q35842618 | ||
Redefining overweight and obesity in rheumatoid arthritis patients. | Q36013923 | ||
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis | Q36320021 | ||
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
Cardiovascular risk factor management in patients with RA compared to matched non-RA patients | Q36795979 | ||
Hypertension in rheumatoid arthritis. | Q37158219 | ||
Challenges in the management of rheumatoid arthritis in developing countries. | Q37265648 | ||
Hypoalphalipoproteinemia in populations of Native American ancestry: an opportunity to assess the interaction of genes and the environment | Q37413192 | ||
Improving doctor-patient communication: examining innovative modalities vis-a-vis effective patient-centric care management technology | Q37461293 | ||
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). | Q37465556 | ||
Obesity paradox does exist | Q37577182 | ||
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives | Q37812524 | ||
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. | Q37883018 | ||
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. | Q37890664 | ||
Cardiovascular risk management in rheumatoid arthritis: A large gap to close | Q38833212 | ||
Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis | Q39995428 | ||
Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis | Q40742537 | ||
Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis | Q40835686 | ||
Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. | Q41928172 | ||
Therapeutic inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia study | Q42781735 | ||
Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. | Q43002728 | ||
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? | Q43255462 | ||
Are obese patients assisted in losing weight? | Q44409621 | ||
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 | ||
Clinical inertia contributes to poor diabetes control in a primary care setting | Q46354116 | ||
Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management. | Q47988471 | ||
Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations | Q48008568 | ||
Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences | Q49849009 | ||
Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs. | Q51129263 | ||
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. | Q51211966 | ||
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. | Q52684480 | ||
Selection bias and information bias in clinical research. | Q53066944 | ||
Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis | Q59394301 | ||
Very early 'Rheumatoid' arthritis cohorts: limited by selection | Q79249639 | ||
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation | Q80932706 | ||
P433 | issue | 3 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 405-414 | |
P577 | publication date | 2019-10-12 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study | |
P478 | volume | 40 |
Search more.